AMENDMENT OF BOARD REGULATION NO. 3, SERIES OF 1981 TO ALLOW CERTAIN PREPARATIONS WITH PROPOXYPHENE NAPSYLATE TO BE PRESCRIBED THROUGH ORDINARY PRESCRIPTION WITHOUT NEED OF INDI…

National Administrative Register [ DDB BOARD REGULATION NO. 5-B, s. 1983, October 19, 1983 ]



Pursuant to the powers vested in it under Section 36 (a) of RA 6425
as amended, and following its decision arrived at in a meeting of
October 19, 1983, the Dangerous Drugs Board hereby amends Board
Regulation No. 3, series of 1981 such that the second paragraph thereof
shall read as follows:

“As exempt preparations these combination products shall be
prescribed through the ordinary prescription form which need not
indicate therein the S-2 license number of the prescribing physician but
which shall contain the name and address of the physician and the
patient.  These products shall however continue to be subject to the
following requirements:

1.            Registration (with the Bureau of Food and Drug)

2.            Records-keeping (in the ordinary prescription book)

3.            Inspection of wholesale and retail trade — All
products falling within the classification herein made are subject to
inspection by the authorized officers of the Bureau of Food Drug and the
Dangerous Drugs Board insofar as regards the purpose and functions of
each of the said officers.

4.            Limitations of imports and exports.

5.            Reports to be furnished by the importers/manufacturers.”

This amendment shall take effect upon completion of its publication
in a newspaper of general circulation once a week for two consecutive
weeks.

Adopted: 19 Oct. 1983

(SGD.) J.C. AZURIN
(Minister of Health)
Chairman